0001437749-16-027085.txt : 20160308 0001437749-16-027085.hdr.sgml : 20160308 20160308170043 ACCESSION NUMBER: 0001437749-16-027085 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20160304 FILED AS OF DATE: 20160308 DATE AS OF CHANGE: 20160308 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Oxford Immunotec Global PLC CENTRAL INDEX KEY: 0001586049 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 000000000 STATE OF INCORPORATION: X0 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 94C INNOVATION DRIVE STREET 2: MILTON PARK CITY: ABINGDON STATE: X0 ZIP: OX14 4RZ BUSINESS PHONE: 44 01235 442780 MAIL ADDRESS: STREET 1: 94C INNOVATION DRIVE STREET 2: MILTON PARK CITY: ABINGDON STATE: X0 ZIP: OX14 4RZ REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Schroeder Jeff R. CENTRAL INDEX KEY: 0001592272 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36200 FILM NUMBER: 161492196 MAIL ADDRESS: STREET 1: C/O OXFORD IMMUNOTEC GLOBAL PLC STREET 2: 94C INNOVATION DRIVE CITY: ABINGDON STATE: X0 ZIP: OX14 4RZ 4 1 rdgdoc.xml FORM 4 X0306 4 2016-03-04 0001586049 Oxford Immunotec Global PLC OXFD 0001592272 Schroeder Jeff R. C/O OXFORD IMMUNOTEC GLOBAL PLC 94C INNOVATION DRIVE ABINGDON, OXFORDSHIRE X0 OX14 4RZ UNITED KINGDOM 1 Chief Commercial Officer Ordinary Shares 2016-03-04 4 A 0 12463 0 A 57081 D Share Option (Right to Buy) 10.21 2016-03-04 4 A 0 51931 0 A 2026-03-04 Ordinary Shares 51931 51931 D Option granted under Issuer's 2013 Share Incentive Plan. Options will become exercisable ratably on the anniversary of the vesting start date from January 1, 2017 through January 1, 2020. /s/ Elizabeth M. Keiley, as Attorney-in-Fact 2016-03-08